首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Frontiers in immunology

缩写:FRONT IMMUNOL

ISSN:1664-3224

e-ISSN:1664-3224

IF/分区:7.0/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引52365
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Aijing Yang,Beibei Zhang,Jiayuan Ju et al. Aijing Yang et al.
Background: Radiation-induced intestinal injury denotes structural and functional impairment of the intestines resulting directly or indirectly from ionizing radiation, such as that employed in radiation therapy for malig...
Weiqing Yang,Sunan Yong,Qiang Zhang et al. Weiqing Yang et al.
Gastrointestinal motility disorders are pathologically characterized by dysregulation of the tripartite network comprising the intestinal immune system, the enteric nervous system, and the gut microbiota. Targeted medicines that target impo...
Huihan Wang,Jinsong Yuan,Hong Wang Huihan Wang
Human Immunodeficiency Virus (HIV), including HIV-1 and HIV-2, is a retrovirus that causes Acquired Immunodeficiency Syndrome (AIDS). HIV primarily targets the human immune system, especially CD4+ T lymphocytes, leading to progressive immun...
Xiangzhen Kong,Hiochon Leong,Min Du et al. Xiangzhen Kong et al.
Background: Aberrant Th17 cell activation and interleukin-17 (IL-17) production drive skin inflammation and progressive fibrosis in systemic sclerosis (SSc). Identifying small molecules that can precisely modulate these p...
Siyin Li,Xiaofang Shu,Juan Shi et al. Siyin Li et al.
Background: Non-criteria antiphospholipid antibodies (aPLs) may be associated with adverse obstetric outcomes in patients who do not meet conventional antiphospholipid syndrome (APS) classification criteria. Their clinica...
Sihan Li,Tianyu He,Jun Chen et al. Sihan Li et al.
Background: First-line immune checkpoint inhibitors (ICIs) have become the standard of care for advanced non-small cell lung cancer (NSCLC). However, whether tumor histology influences the efficacy of ICIs remains unclear...
Kun Xu,Ruoxue Cai,Zijian Sun et al. Kun Xu et al.
Background: Either Programmed cell death protein 1 (PD-1)/Programmed cell death-Ligand protein 1 (PD-L1) inhibitors plus chemotherapy or anti-angiogenic agents plus chemotherapy has become first-line therapy in negative o...
Renbin Zhao,Xiangmei Yao,Shuai Feng et al. Renbin Zhao et al.
Background: The Lymphocyte subsets in treatment-naïve patients and their variations among different genetic subtypes and age groups remain poorly characterized. ...
Jiao Fu,Yi Dai,Qiaoling Wang et al. Jiao Fu et al.
Ovarian cancer is characterized by extensive peritoneal dissemination, frequent recurrence, and chemoresistance. Glycolytic reprogramming has emerged as a central metabolic adaptation in ovarian cancer, but its significance extends beyond i...
Mengxiao Zhao,Liwei Chen,Yuhang Chen et al. Mengxiao Zhao et al.
Background: CD100/SEMA4D functions as a critical co-stimulatory molecule in T cell responses, existing in both membrane-bound (mCD100) and soluble (sCD100) forms. Previous studies have shown that CD100 enhances CD8+ T cel...